• Amir Qaseem, Cristin A Mount, Karen Campos, Robert M McLean, Samantha Tierney, J Thomas Cross, Nick Fitterman, Performance Measurement Committee of the American College of Physicians, Rebecca A Andrews, Peter Basch, Caroline L Goldzweig, Scott T MacDonald, Catherine H MacLean, Suja M Mathew, Rhea E Powell, and Sameer D Saini.
• American College of Physicians, Philadelphia, Pennsylvania (A.Q., K.C., S.T.).
• Ann. Intern. Med. 2023 Oct 1; 176 (10): 138613911386-1391.

AbstractPrimary osteoporosis is characterized by decreasing bone mass and density and reduced bone strength that leads to a higher risk for fracture, especially hip and spine fractures. The prevalence of osteoporosis in the United States is estimated at 12.6% for adults older than 50 years. Although it is most frequently diagnosed in White and Asian females, it still affects males and females of all ethnicities. Osteoporosis is considered a major health issue, which has prompted the development and use of several performance measures to assess and improve the effectiveness of screening, diagnosis, and treatment. These performance measures are often used in accountability, public reporting, and/or payment programs. However, the reliability, validity, evidence, attribution, and meaningfulness of performance measures have been questioned. The purpose of this paper is to present a review of current performance measures on osteoporosis and inform physicians, payers, and policymakers in their selection of performance measures for this condition. The Performance Measurement Committee identified 6 osteoporosis performance measures relevant to internal medicine physicians, only 1 of which was found valid at all levels of attribution. This paper also proposes a performance measure concept to address a performance gap for the initial approach to therapy for patients with a new diagnosis of osteoporosis based on the current American College of Physicians guideline.

32 keywords...

hide…